Molecular pathogenesis of pancreatic cancer
TJ Grant, K Hua, A Singh - Progress in molecular biology and translational …, 2016 - Elsevier
… Pancreatic cancers arise predominantly from ductal epithelial cells of the exocrine pancreas
and are of the ductal adenocarcinoma histological subtype (PDAC). PDAC is an aggressive …
and are of the ductal adenocarcinoma histological subtype (PDAC). PDAC is an aggressive …
Molecular pathogenesis of pancreatic cancer
… for earlyscreening for pancreas cancer by molecular analysis of either … pancreatic cancer
(familial pancreatic cancer), andgreater than 600 have a family member with pancreatic cancer, …
(familial pancreatic cancer), andgreater than 600 have a family member with pancreatic cancer, …
Molecular pathogenesis of pancreatic cancer
… of the molecular biology of pancreatic cancer can now be brought … pancreatic cancer will
be fought and won. First, patients with a family history of pancreatic cancer or of other cancers …
be fought and won. First, patients with a family history of pancreatic cancer or of other cancers …
Molecular pathogenesis of pancreatic cancer and clinical perspectives
D Matthaios, P Zarogoulidis, I Balgouranidou… - Oncology, 2011 - karger.com
… Pancreatic cancer remains stubbornly resistant to many key cytotoxic chemotherapeutic
agents and novel targeted therapies. The molecular heterogeneity of this cancer … of pancreatic …
agents and novel targeted therapies. The molecular heterogeneity of this cancer … of pancreatic …
Molecular pathogenesis of pancreatic cancer: advances and challenges
T Welsch, J Kleeff, H Friess - Current Molecular Medicine, 2007 - ingentaconnect.com
… Although crucial advances in our understanding of the molecular pathogenesis of the disease
have been made, the exceptional aggressiveness of PDAC remains largely unexplained. …
have been made, the exceptional aggressiveness of PDAC remains largely unexplained. …
Pancreatic cancer: molecular pathogenesis and new therapeutic targets
HH Wong, NR Lemoine - Nature reviews Gastroenterology & …, 2009 - nature.com
… for pancreatic cancer that have been tested in clinical trials. … These data suggest that
treatments for pancreatic cancer … in therapies for pancreatic cancer that have been tested both …
treatments for pancreatic cancer … in therapies for pancreatic cancer that have been tested both …
The molecular pathogenesis of pancreatic cancer: clarifying a complex circuitry
AK Rustgi - Genes & development, 2006 - genesdev.cshlp.org
The preponderance of pancreatic malignancies is constituted by pancreatic ductal
adenocarcinomas, abbreviated as either PDA or PDAC in the literature and used interchangeably …
adenocarcinomas, abbreviated as either PDA or PDAC in the literature and used interchangeably …
Pancreatic cancer: from molecular pathogenesis to targeted therapy
… pancreatic ductal … pancreatic cancer refers almost always to the PDAC. In this review we
are also dealing with the PDAC (from now on will be referred as pancreatic cancer or pancreatic …
are also dealing with the PDAC (from now on will be referred as pancreatic cancer or pancreatic …
Molecular pathogenesis of pancreatic cancer
… pathogenesis of pancreatic carcinoma and to describe their functions within the biological
pathways that lead to pancreatic … of molecular tumor progression of pancreatic carcinoma, as …
pathways that lead to pancreatic … of molecular tumor progression of pancreatic carcinoma, as …
Molecular pathogenesis and targeted therapy of pancreatic cancer
S Tanaka - Annals of surgical oncology, 2016 - Springer
… pancreatic neuroendocrine tumor. This review summarizes the molecular pathogenesis of
pancreatic cancer … factors, and promising concepts “cancer stemness” and “stromal niche” for …
pancreatic cancer … factors, and promising concepts “cancer stemness” and “stromal niche” for …
相关搜索
- molecular biology of pancreatic cancer
- molecular pathology pancreatic cancer
- molecular pathways pancreatic cancer
- precursor lesions pancreatic cancer
- molecular pathogenesis targeted therapy
- advances and challenges pancreatic cancer
- molecular subtyping of pancreatic cancer
- molecular targets treatment of pancreatic cancer
- molecular drivers pancreatic cancer pathogenesis
- molecular analysis familial pancreatic cancer
- molecular events pancreatic cancer
- molecular mechanism pancreatic cancer
- molecular characterization pancreatic cancer
- molecular aspects of carcinogenesis pancreatic cancer
- molecular biomarkers pancreatic cancer
- molecular signature pancreatic cancer